INTRODUCTION: Early warning of future hypoglycemic and hyperglycemic events can improve the safety of type 1 diabetes mellitus (T1DM) patients. The aim of this study is to design and evaluate a hypoglycemia/hyperglycemia early warning system (EWS) for T1DM patients under sensor-augmented pump (SAP) therapy. METHODS: The EWS is based on the combination of data-driven online adaptive prediction models and a warning algorithm. Three modeling approaches have been investigated: (i) autoregressive (ARX) models, (ii) auto-regressive with an output correction module (cARX) models, and (iii) recurrent neural network (RNN) models. The warning algorithm performs postprocessing of the models' outputs and issues alerts if upcoming hypoglycemic/hyperglycemic events are detected. Fusion of the cARX and RNN models, due to their complementary prediction performances, resulted in the hybrid autoregressive with an output correction module/recurrent neural network (cARN)-based EWS. RESULTS: The EWS was evaluated on 23 T1DM patients under SAP therapy. The ARX-based system achieved hypoglycemic (hyperglycemic) event prediction with median values of accuracy of 100.0% (100.0%), detection time of 10.0 (8.0) min, and daily false alarms of 0.7 (0.5). The respective values for the cARX-based system were 100.0% (100.0%), 17.5 (14.8) min, and 1.5 (1.3) and, for the RNN-based system, were 100.0% (92.0%), 8.4 (7.0) min, and 0.1 (0.2). The hybrid cARN-based EWS presented outperforming results with 100.0% (100.0%) prediction accuracy, detection 16.7 (14.7) min in advance, and 0.8 (0.8) daily false alarms. CONCLUSION: Combined use of cARX and RNN models for the development of an EWS outperformed the single use of each model, achieving accurate and prompt event prediction with few false alarms, thus providing increased safety and comfort.
INTRODUCTION: Early warning of future hypoglycemic and hyperglycemic events can improve the safety of type 1 diabetes mellitus (T1DM) patients. The aim of this study is to design and evaluate a hypoglycemia/hyperglycemia early warning system (EWS) for T1DM patients under sensor-augmented pump (SAP) therapy. METHODS: The EWS is based on the combination of data-driven online adaptive prediction models and a warning algorithm. Three modeling approaches have been investigated: (i) autoregressive (ARX) models, (ii) auto-regressive with an output correction module (cARX) models, and (iii) recurrent neural network (RNN) models. The warning algorithm performs postprocessing of the models' outputs and issues alerts if upcoming hypoglycemic/hyperglycemic events are detected. Fusion of the cARX and RNN models, due to their complementary prediction performances, resulted in the hybrid autoregressive with an output correction module/recurrent neural network (cARN)-based EWS. RESULTS: The EWS was evaluated on 23 T1DM patients under SAP therapy. The ARX-based system achieved hypoglycemic (hyperglycemic) event prediction with median values of accuracy of 100.0% (100.0%), detection time of 10.0 (8.0) min, and daily false alarms of 0.7 (0.5). The respective values for the cARX-based system were 100.0% (100.0%), 17.5 (14.8) min, and 1.5 (1.3) and, for the RNN-based system, were 100.0% (92.0%), 8.4 (7.0) min, and 0.1 (0.2). The hybrid cARN-based EWS presented outperforming results with 100.0% (100.0%) prediction accuracy, detection 16.7 (14.7) min in advance, and 0.8 (0.8) daily false alarms. CONCLUSION: Combined use of cARX and RNN models for the development of an EWS outperformed the single use of each model, achieving accurate and prompt event prediction with few false alarms, thus providing increased safety and comfort.
Authors: Chiara Zecchin; Andrea Facchinetti; Giovanni Sparacino; Giuseppe De Nicolao; Claudio Cobelli Journal: IEEE Trans Biomed Eng Date: 2012-02-24 Impact factor: 4.538
Authors: Scott M Pappada; Brent D Cameron; Paul M Rosman; Raymond E Bourey; Thomas J Papadimos; William Olorunto; Marilyn J Borst Journal: Diabetes Technol Ther Date: 2011-02 Impact factor: 6.118
Authors: E I Georga; V C Protopappas; D Ardigo; M Marina; I Zavaroni; D Polyzos; D I Fotiadis Journal: IEEE J Biomed Health Inform Date: 2012-09-19 Impact factor: 5.772
Authors: John B Buse; Yogish C Kudva; Tadej Battelino; Stephen N Davis; John Shin; John B Welsh Journal: Diabetes Technol Ther Date: 2012-04-23 Impact factor: 6.118
Authors: Adiwinata Gani; Andrei V Gribok; Srinivasan Rajaraman; W Kenneth Ward; Jaques Reifman Journal: IEEE Trans Biomed Eng Date: 2008-09-16 Impact factor: 4.538
Authors: Emily B Schroeder; Stan Xu; Glenn K Goodrich; Gregory A Nichols; Patrick J O'Connor; John F Steiner Journal: J Diabetes Complications Date: 2017-04-11 Impact factor: 2.852
Authors: Eleni I Georga; Vasilios C Protopappas; Demosthenes Polyzos; Dimitrios I Fotiadis Journal: Med Biol Eng Comput Date: 2015-03-15 Impact factor: 2.602
Authors: Steven D Imrisek; Matthew Lee; Dan Goldner; Harpreet Nagra; Lindsey M Lavaysse; Jamillah Hoy-Rosas; Jeff Dachis; Lindsay E Sears Journal: JMIR Diabetes Date: 2022-05-03
Authors: Omar Diouri; Monika Cigler; Martina Vettoretti; Julia K Mader; Pratik Choudhary; Eric Renard Journal: Diabetes Metab Res Rev Date: 2021-03-24 Impact factor: 4.876